Mid- to Long-term Outcomes Following Primary Augmentation With B-Lite Lightweight Breast Implants: A Prospective Multicenter Postmarketing Clinical Follow-up Study
Aesthetic Surgery Journal · 18.08.2026 · 46 (9) · NP88-NP96
DOI: 10.1093/asj/sjag105 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 28.07.2026. Verfasst von Matthias Reichenberger und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Implantation, Breast Implants. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: POLYTECH Health and Aesthetics GmbH.
Abstract (Originalsprache)
Background
Lightweight breast implants (B-Lite) integrate air-filled microspheres into silicone gel to reduce implant weight by up to 30% while maintaining volume and mechanical properties. Long-term prospective data in primary augmentation remain limited.
Objectives
To evaluate clinical performance, safety, satisfaction, and quality of life (QoL) outcomes following primary augmentation with B-Lite implants.
Methods
This multicenter, prospective, single-arm manufacturer-sponsored postmarketing clinical follow-up (PMCF) study enrolled genetically female patients (18-60 years) undergoing bilateral primary breast augmentation. Implants (round or anatomical; POLYsmoooth, POLYtxt, MESMO, or Microthane; 200-755 cc) were placed through inframammary incisions using a standardized technique. The primary endpoint was ≥1 bra-cup increase at 12 months; secondary endpoints included QoL (Body Esteem, Rosenberg, shortened Tennessee, RAND SF-36), satisfaction, and adverse events (AEs) such as capsular contracture (Baker III-IV), rupture, breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), and reoperation.
Results
In all, 101 patients (mean age 32.7 ± 8.0 years; BMI 20.9 ± 1.8) underwent augmentation. At 12 months, ≥1-cup increase occurred in 92% (95% CI, 84%-97%). No Baker III/IV contracture, rupture, or BIA-ALCL occurred. The most frequent AE was transient sensory change (8.9%); others were infrequent and mainly procedure related. Kaplan–Meier reoperation risk was 6.9% at 1 year and 9.9% at 5 years. Patient satisfaction averaged 98.6% with 0% regret; surgeons were satisfied or very satisfied at 97% to 100%. QoL showed durable gains in Body Esteem–sexual attractiveness and Rosenberg; SF-36 composites remained stable.
Conclusions
Lightweight B-Lite implants showed high effectiveness, very high satisfaction, and a favorable safety profile through 3 to 5 years. Level of Evidence: 2 For image description, please refer to the figure legend and surrounding text.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- POLYTECH Health and Aesthetics GmbH
Zitieren
APA
Reichenberger, M., Hedén, P., & Germann, G. (2026). Mid- to Long-term Outcomes Following Primary Augmentation With B-Lite Lightweight Breast Implants: A Prospective Multicenter Postmarketing Clinical Follow-up Study. Aesthetic Surgery Journal, 46(9), NP88-NP96. https://doi.org/10.1093/asj/sjag105
Vancouver
Reichenberger M, Hedén P, Germann G. Mid- to Long-term Outcomes Following Primary Augmentation With B-Lite Lightweight Breast Implants: A Prospective Multicenter Postmarketing Clinical Follow-up Study. Aesthetic Surgery Journal. 2026;46(9):NP88-NP96. doi:10.1093/asj/sjag105
BibTeX
@article{Reichenberger2026,
author = {Reichenberger, Matthias and Hedén, Per and Germann, Guenter},
title = {Mid- to Long-term Outcomes Following Primary Augmentation With B-Lite Lightweight Breast Implants: A Prospective Multicenter Postmarketing Clinical Follow-up Study},
journal = {Aesthetic Surgery Journal},
year = {2026},
volume = {46},
number = {9},
pages = {NP88--NP96},
doi = {10.1093/asj/sjag105}
}
EUVIMED